NMR Structure Elucidation, Process Research and Development, Merck & Co., Inc. , Rahway, New Jersey 07065, United States.
Medical Oncology Branch, Center for Cancer Research, National Cancer Institute , Bethesda, Maryland 20892, United States.
J Org Chem. 2016 Nov 18;81(22):10631-10640. doi: 10.1021/acs.joc.6b02380. Epub 2016 Nov 10.
An extract of Eudistoma sp. provided eudistidine C (1), a heterocyclic alkaloid with a novel molecular framework. Eudistidine C (1) is a racemic natural product composed of a tetracyclic core structure further elaborated with a p-methoxyphenyl group and a phenol-substituted aminoimidazole moiety. This compound presented significant structure elucidation challenges due to the large number of heteroatoms and fully substituted carbons. These issues were mitigated by application of a new NMR pulse sequence (LR-HSQMBC) optimized to detect four- and five-bond heteronuclear correlations and the use of computer-assisted structure elucidation software. Synthesis of eudistidine C (1) was accomplished in high yield by treating eudistidine A (2) with 4(2-amino-1H-imidazol-5-yl)phenol (4) in DMSO. Synthesis of eudistidine C (1) confirmed the proposed structure and provided material for further biological characterization. Treatment of 2 with various nitrogen heterocycles and electron-rich arenes provided a series of analogues (5-10) of eudistidine C. Chiral-phase HPLC resolution of epimeric eudistidine C provided (+)-(R)-eudistidine C (1a) and (-)-(S)-eudistidine C (1b). The absolute configuration of these enantiomers was assigned by ECD analysis. (-)-(S)-Eudistidine C (1b) modestly inhibited interaction between the protein binding domains of HIF-1α and p300. Compounds 1, 2, and 6-10 exhibited significant antimalarial activity against Plasmodium falciparum.
一种来自 Eudistoma sp. 的提取物提供了 eudistidine C(1),一种具有新颖分子骨架的杂环生物碱。Eudistidine C(1)是一种外消旋天然产物,由四环核心结构进一步修饰而成,带有对甲氧基苯基和酚取代的氨基咪唑部分。由于杂原子和全取代碳原子的数量众多,该化合物的结构阐明具有很大的挑战性。这些问题通过应用新的 NMR 脉冲序列(LR-HSQMBC)得以缓解,该序列优化用于检测四键和五键异核相关,并使用计算机辅助结构阐明软件。通过用 4-(2-氨基-1H-咪唑-5-基)苯酚(4)处理 eudistidine A(2),以高产率合成了 eudistidine C(1)。eudistidine C(1)的合成证实了所提出的结构,并提供了用于进一步生物学特征描述的材料。用各种氮杂环和富电子芳环处理 2 得到了一系列 eudistidine C 的类似物(5-10)。eudistidine C 的外消旋混合物通过手性 HPLC 拆分得到了 (+)-(R)-eudistidine C(1a)和 (-)-(S)-eudistidine C(1b)。通过 ECD 分析确定了这些对映异构体的绝对构型。(-)-(S)-Eudistidine C(1b)适度抑制了 HIF-1α 和 p300 的蛋白结合结构域之间的相互作用。化合物 1、2 和 6-10 对疟原虫 Plasmodium falciparum 表现出显著的抗疟活性。